I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A ..:
Xin He (48101)
;
Guangchao He (8194926)
;
Zhaoxing Chu (7536365)
...
https://figshare.com/articles/dataset/Discovery_of_the_First_Potent_IDO1_IDO2_Dual_Inhibitors_A_Promising_Strategy_for_Cancer_Immunotherapy/17113534. , 2021
Link:
https://doi.org/10.1021/acs.jmedchem.1c01305.s002
RT Journal T1
Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17113534&Exemplar=1&LAN=DE A1 Xin He (48101) A1 Guangchao He (8194926) A1 Zhaoxing Chu (7536365) A1 Huanhuan Wu (339728) A1 Junjie Wang (172690) A1 Yiran Ge (8194932) A1 Hui Shen (66625) A1 Shan Zhang (431282) A1 Jinxi Shan (11784280) A1 Kewen Peng (8194929) A1 Zhifeng Wei (11453658) A1 Yi Zou (439002) A1 Yungen Xu (1434802) A1 Qihua Zhu (1555147) YR 2021 K1 Biochemistry K1 Medicine K1 Molecular Biology K1 Pharmacology K1 Biotechnology K1 Immunology K1 Cancer K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 unsatisfactory clinical efficacies K1 preliminary mechanistic studies K1 first inhibitor targeting K1 emerging evidence suggests K1 tumor immune escape K1 144 nm ) K1 selective ido1 inhibitors K1 first potent ido1 K1 ido2 dual inhibitors K1 2 dual inhibitors K1 selectively inhibiting ido1 K1 50 </ sub K1 4t </ b K1 inhibiting ido1 K1 vivo </ K1 vitro </ K1 tumor immunotherapy K1 28 nm K1 ido1 ic K1 synergistic effects K1 promising strategy K1 inhibitory activity K1 important role K1 ido2 ic K1 human tumors K1 concomitant inhibition K1 cancer treatment K1 antitumor potency K1 antitumor effect K1 4 %) K1 2 may JF https://figshare.com/articles/dataset/Discovery_of_the_First_Potent_IDO1_IDO2_Dual_Inhibitors_A_Promising_Strategy_for_Cancer_Immunotherapy/17113534 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.1c01305.s002 DO https://doi.org/10.1021/acs.jmedchem.1c01305.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)